6
Clinical Trials associated with CKD-393A Randomized, Open-label, Single Dose, Crossover Study to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-393 in Healthy Volunteers
Study to evaluate the food effect on pharmacokinetic profiles and safety of CKD-393 in healthy volunteers
A Randomized, Open-label, Single Dose, Crossover Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions
A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions
A Randomized, Open-label, Single Dose, Crossover Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393 in Healthy Volunteers Under Fed Conditions
Objective
- Evaluation of the pharmacokinetic properties and safety of CKD-393 0.25/50/750 mg oral administration in healthy adults under fed condition.
100 Clinical Results associated with CKD-393
100 Translational Medicine associated with CKD-393
100 Patents (Medical) associated with CKD-393
100 Deals associated with CKD-393